Immutep (IMMP) Inventory (2011 - 2012)
Immutep's (IMMP) quarterly Inventory came in at $193746.6 in Q2 2012, down 14.86% on a YoY basis from $227567.7 in Q3 2011, and down 14.86% quarter-over-quarter from $227567.7 in Q2 2011.
Powered by 
Analysis
Immutep (IMMP) Inventory (2011 - 2012) Analysis & Trends
Immutep (IMMP) has reported Inventory for 2 consecutive years, with $193746.6 the latest figure, recorded in Q2 2012.
- For the quarter ending Q2 2012, Inventory fell 14.86% year-over-year to $193746.6; the trailing twelve-month figure through Jun 2012 stood at $193746.6 (down 14.86% YoY), and the FY2012 full-year result was $193746.6, down 8.59% from the prior year.
- Inventory retreated to $193746.6 in Q2 2012 per IMMP's latest filing, from $227567.7 in the prior quarter.
- Across five years, Inventory topped out at $227567.7 in Q2 2011 and bottomed at $193746.6 in Q2 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Immutep | 51.68 Mn | 51.68 Mn | - | - |